← Open Payments lookup

MICHELLE BOONE: Open Payments

NPI 1215310784 · NASHVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$309 in 13 payments from 9 companies in 2025. Trend: 2023 $33 · 2024 $88 · 2025 $309

Food & beverage: $309
CompanyPaymentsAmount
Corcept Therapeutics1$111
Otsuka America Pharmaceutical, Inc.3$60
ABBVIE INC.2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$29
Axsome Therapeutics, Inc.1$16
Vanda Pharmaceuticals Inc.1$16
Teva Pharmaceuticals USA, Inc.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$14
Averitas Pharma Inc.1$14

Products named: Korlym, REXULTI, VRAYLAR, CAPLYTA, Auvelity, HETLIOZ, AUSTEDO XR, TRINTELLIX.

Industry payments across AR — which companies pay providers there.